Ignite Creation Date:
2025-12-26 @ 11:00 AM
Ignite Modification Date:
2026-01-13 @ 9:16 AM
Study NCT ID:
NCT01246206
Status:
COMPLETED
Last Update Posted:
2018-06-18
First Post:
2010-11-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT
Sponsor:
Barbara Ann Karmanos Cancer Institute
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hematological Malignancies | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | ● Non-Hodgkin lymphoma, | View |
| None | ● Hodgkin disease, | View |
| None | ● Acute Myelogenous or Acute Lymphocytic Leukemia | View |
| None | ● Myelodysplastic Syndromes, | View |
| None | ● Chronic Myelogenous Leukemia | View |
| None | ● Multiple Myeloma | View |
| None | ● Chronic Lymphocytic Leukemia | View |
| None | ● Myelofibrosis and other myeloproliferative disorders; | View |